Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Ling Wang
Independent
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
136
TOTAL CITATIONS
7
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Safety, Tolerability and Immunogenicity of a Recombinant Adenovirus Type 5 Vectored COVID-19 Vaccine in Healthy Adults in China: Preliminary Report of a First-In Human Single-Center, Open-Label, Dose-Escalating Clinical Trial
Number of pages: 21
Posted: 17 Jun 2020
Feng-Cai Zhu
,
Yu-Hua Li
,
Xu-Hua Guan
,
Li-Hua Hou
,
Wen-Juan Wang
,
Jingxin Li
,
Shi-Po Wu
,
Bu-Sen Wang
,
Zhao Wang
,
Lei Wang
,
Si-Yue Jia
,
Hu-Dachuan Jiang
, Ling Wang,
Tao Jiang
,
Yi Hu
,
Jing-Bo Gou
,
Shabei Xu
,
Jun-Jie Xu
,
Xue-Wen Wang
,
Wei Wang
and
Wei Chen
Jiangsu Provincial Center for Disease Control and Prevention - NHC Key Laboratory of Enteric Pathogenic Microbiology, Independent, Independent, Independent, Independent, Chinese Center for Disease Control and Prevention (China CDC) - Jiangsu Provincial Center for Disease Control and Prevention, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Independent, Huazhong University of Science and Technology - Department of Neurology, Independent, Independent, Huazhong University of Science and Technology - Department of Neurology and Academy of Military Medical Sciences - Institute of Biotechnology
Downloads
136
(453,056)
Citation
7
View PDF
Download
Abstract:
COVID-19; Vaccine; SARS-CoV-2; Clinical trial
Feedback